Cormorant Asset Management, LP

Position in COGT — Cogent Biosciences, Inc.

CIK 1583977 BOSTON, MA

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,870,000

-$3,828,000 QoQ

Shares Held

100,000

-50.0% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#135

of 321 holders

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. COGT ranks #41 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	640,000	$214,265,600
2	BBOT	BridgeBio Oncology Therapeutics, Inc.	17,878,594	$136,234,886
3	PBLS	Parabilis Medicines, Inc.	4,615,612	$126,329,300
4	RAPP	Rapport Therapeutics, Inc.	2,657,521	$110,738,900
5	ERAS	Erasca, Inc.	6,000,000	$109,920,000
6	EWTX	Edgewise Therapeutics, Inc.	2,510,000	$101,981,300
7	EYPT	EyePoint, Inc.	7,000,000	$100,100,000
8	ALMS	Alumis Inc.	3,285,596	$92,456,671

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,870,000	100,000	-50.0%	Shares	Defined	2026-08-14
2026-03-31	$7,698,000	200,000	-11.1%	Shares	Defined	2026-05-15
2025-12-31	$7,992,000	225,000	-77.5%	Shares	Defined	2026-02-17
2023-09-30	$9,750,000	1,000,000	0.0%	Shares	Defined	2023-11-14
2023-06-30	$11,840,000	1,000,000	+42.9%	Shares	Defined	2023-08-14
2023-03-31	$7,553,000	700,000	-22.2%	Shares	Defined	2023-05-15
2022-12-31	$10,404,000	900,000	-37.9%	Shares	Defined	2023-02-14
2022-09-30	$21,634,000	1,450,000	+93.3%	Shares	Defined	2022-11-14
2022-06-30	$6,765,000	750,000	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.